SLP

Simulations Plus Inc

SLP, USA

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.

https://www.simulations-plus.com

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
SLP
stock
SLP

Simulations Plus (NASDAQ:SLP) Updates FY 2026 Earnings Guidance MarketBeat

Read more →
SLP
stock
SLP

Russell Investments Group Ltd. Sells 112,542 Shares of Simulations Plus, Inc. $SLP MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-08-31)

Rating:

STRONG BUY

Target Price:

$22.3333

Analyst Picks

Strong Buy

5

Buy

0

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-08-31)

Health Score

Price to Book Ratio (P/B)

-

Very High

3.15

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-0.55 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-0.52 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very High

27.47 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very High

0.06

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 98.29% of the total shares of Simulations Plus Inc

1.

BlackRock Inc

(12.4308%)

since

2025/06/30

2.

Conestoga Capital Advisors, LLC

(6.3702%)

since

2025/06/30

3.

Vanguard Group Inc

(5.843%)

since

2025/06/30

4.

iShares Core S&P Small-Cap ETF

(4.859%)

since

2025/08/31

5.

Ameriprise Financial Inc

(4.3496%)

since

2025/06/30

6.

HHG PLC

(4.0401%)

since

2025/06/30

7.

Morgan Stanley - Brokerage Accounts

(3.9829%)

since

2025/06/30

8.

Janus Henderson Venture D

(3.7723%)

since

2025/06/30

9.

Janus Henderson US Small Cap Growth

(3.7723%)

since

2025/06/30

10.

State Street Corp

(3.3472%)

since

2025/06/30

11.

Millennium Management LLC

(2.7569%)

since

2025/06/30

12.

Vanguard Total Stock Mkt Idx Inv

(2.5494%)

since

2025/07/31

13.

Dimensional Fund Advisors, Inc.

(2.4117%)

since

2025/06/30

14.

Conestoga Small Cap Growth

(2.0404%)

since

2025/06/30

15.

Geode Capital Management, LLC

(1.9767%)

since

2025/06/30

16.

iShares Russell 2000 ETF

(1.9764%)

since

2025/08/31

17.

Ranger Investment Management LP

(1.9187%)

since

2025/06/30

18.

Kennedy Capital Management Inc

(1.9101%)

since

2025/06/30

19.

CT (Lux) American Smaller Com 9U USD

(1.8946%)

since

2025/07/31

20.

Rockefeller Capital Management L.P.

(1.8838%)

since

2025/06/30

21.

Tributary Capital Management, LLC

(1.795%)

since

2025/06/30

22.

Tributary Small Cap Equity

(1.7818%)

since

2025/08/31

23.

First Light Asset Management, LLC

(1.7745%)

since

2025/06/30

24.

Deerfield Management Co

(1.7593%)

since

2025/06/30

25.

Ranger Small Cap

(1.542%)

since

2025/06/30

26.

Stephens Inv Mgmt Group LLC

(1.3344%)

since

2025/06/30

27.

Stephens Small Cap Growth

(1.3305%)

since

2025/06/30

28.

Royce & Associates, LP

(1.3166%)

since

2025/06/30

29.

Kennedy Small Cap Value

(1.3095%)

since

2025/06/30

30.

Northern Trust Corp

(1.2403%)

since

2025/06/30

31.

CT American Smaller Coms(US) InstAccGBP

(1.0902%)

since

2025/07/31

32.

Tributary Small Company Instl

(1.0882%)

since

2025/07/31

33.

Bank of America Corp

(1.0395%)

since

2025/06/30

34.

Nicholas Small-Cap Growth Equity

(0.9021%)

since

2025/06/30

35.

Nicholas Limited Edition I

(0.9021%)

since

2025/06/30

36.

Vanguard Institutional Extnd Mkt Idx Tr

(0.8899%)

since

2025/07/31

37.

Fidelity Small Cap Index

(0.8396%)

since

2025/06/30

38.

North Star Micro Cap I

(0.785%)

since

2025/07/31

39.

Royce Micro Cap Trust

(0.7621%)

since

2025/06/30

40.

iShares Russell 2000 Growth ETF

(0.7215%)

since

2025/08/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-11-30

EPS Estimate

0.1717

Latest Release

Date

2025-08-31

EPS Actual

0.1

EPS Estimate

0.0986

EPS Difference

0.0014

Surprise Percent

1.4199%

Investing Fit Scorecard

(Last Updated 2025-08-31)

Deep Value
Potential Value Candidate(5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.8)
GARP
Fair GARP(4)
Growth
Weak Growth Prospect(2.5)
Momentum
Moderate Momentum(4)
Net Net
Possible Net-Net(4)
Quality
Moderate Quality(6)
Value
Fair Value(5.5)

Income Statement

(Last Updated 2025-08-31)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-08-31)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-08-31)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.